Hemophilia B

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
FDA Approves New Treatment Option for Eczema
12/22/2016
The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.
12/22/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/22/2016
The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.
12/22/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/22/2016
The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.
12/22/2016
Smoking cessation
Smoking cessation
FDA Removes Black Box Warning From Smoking Cessation Drug
12/19/2016
Based on the results of a recent clinical trial, the FDA has decided to remove its black box warning from the label of Chantix (varenicline).
12/19/2016
FDA
FDA
FDA: Use of General Anesthetics, Sedatives May Harm Young Children
12/16/2016
Children’s brain development may be adversely affected by the use of general anesthetic and sedation drugs, the FDA said in a warning statement.
12/16/2016
Atopic Dermatitis
Atopic Dermatitis
FDA approves Pfizer's eczema ointment
12/15/2016
By Reuters Staff
12/15/2016
Atopic Dermatitis
Atopic Dermatitis
FDA approves Pfizer's eczema ointment
12/15/2016
By Reuters Staff
12/15/2016
Atopic Dermatitis
Atopic Dermatitis
FDA approves Pfizer's eczema ointment
12/15/2016
By Reuters Staff
12/15/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/14/2016
The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
12/14/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/14/2016
The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
12/14/2016